Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Comparison of Evolut FX Versus Sapien 3 Ultra Resilia.

NCT: NCT06470022 · ACTIVE_NOT_RECRUITING

NCT IDNCT06470022
StatusACTIVE_NOT_RECRUITING
Start Date2024-08-09
Completion2036-11-20
SponsorChristian Juhl Terkelsen (OTHER)
First posted
Last updated

Brief Summary

To compare outcome in patients randomized to treatment with Evolut FX versus Sapien 3 Ultra Resilia.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑